Garg Pushkal

EVP Chief R&D

Garg Pushkal has filed 6 SEC Form 4 filings (76 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Mar 6, 2026.

On the most recent filing, Garg Pushkal is listed as EVP Chief R&D at ALNYLAM PHARMACEUTICALS, INC. Inside the rolling window, Garg Pushkal reported no open-market purchases and 9 open-market sales totaling $8.1M in ALNY. The largest disclosed transaction in the window is a sale of 4,627 ALNY shares on Feb 27, 2026, worth $1.5M.

Companies traded

Other insiders at ALNY

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$8.1M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ALNYSale$746KMar 6SEC ↗
ALNYSale$779KMar 6SEC ↗
ALNYSale$563KMar 4SEC ↗
ALNYSale$568KMar 4SEC ↗
ALNYSale$1.5MMar 2SEC ↗
ALNYSale$695KFeb 17SEC ↗
ALNYSale$548KJan 14SEC ↗
ALNYSale$1.3MOct 3SEC ↗
ALNYSale$1.4MOct 3SEC ↗
Showing 1–9 of 9
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Garg Pushkal made?

Garg Pushkal has filed 6 SEC Form 4 filings (76 transaction rows) across 1 company since 2025.

Which companies does Garg Pushkal trade?

Garg Pushkal has filed SEC Form 4 disclosures for 1 company, including ALNY.

When was Garg Pushkal's most recent SEC Form 4 filing?

Garg Pushkal's most recent SEC Form 4 filing on Tracefour is dated Mar 6, 2026.

What is Garg Pushkal's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Garg Pushkal is listed as EVP Chief R&D.

What is Garg Pushkal's total buy and sell value in the current window?

Inside the rolling retention window, Garg Pushkal bought $0 and sold $8.1M based on SEC Form 4 filings.

What was Garg Pushkal's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 4,627 ALNY shares on 2026-02-27, worth $1.5M, per SEC Form 4 filings.